SMMT
Price
$17.61
Change
+$0.47 (+2.74%)
Updated
Sep 4 closing price
Capitalization
14.04B
65 days until earnings call
Intraday BUY SELL Signals
SNDX
Price
$20.56
Change
-$0.12 (-0.58%)
Updated
Sep 4 closing price
Capitalization
1.84B
52 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SMMT vs SNDX

SMMT vs SNDX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SMMT vs. SNDX commentary
Sep 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMMT is a Hold and SNDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2026
Stock price -- (SMMT: $17.60 vs. SNDX: $20.56)
Brand notoriety: SMMT and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SMMT: 132% vs. SNDX: 88%
Market capitalization -- SMMT: $14.04B vs. SNDX: $1.84B
SMMT [@Biotechnology] is valued at $14.04B. SNDX’s [@Biotechnology] market capitalization is $1.84B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMMT’s FA Score shows that 1 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • SMMT’s FA Score: 1 green, 4 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, both SMMT and SNDX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SMMT’s TA Score shows that 5 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • SMMT’s TA Score: 5 bullish, 5 bearish.
  • SNDX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SMMT is a better buy in the short-term than SNDX.

Price Growth

SMMT (@Biotechnology) experienced а +28.22% price change this week, while SNDX (@Biotechnology) price change was +5.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.22%. For the same industry, the average monthly price growth was +5.23%, and the average quarterly price growth was +2396.59%.

Reported Earning Dates

SMMT is expected to report earnings on Nov 11, 2026.

SNDX is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($14B) has a higher market cap than SNDX($1.84B). SMMT YTD gains are higher at: 0.658 vs. SNDX (-2.142). SNDX has higher annual earnings (EBITDA): -178.35M vs. SMMT (-859.78M). SMMT has more cash in the bank: 691M vs. SNDX (554M). SMMT has less debt than SNDX: SMMT (20.4M) vs SNDX (589M). SNDX has higher revenues than SMMT: SNDX (252M) vs SMMT (0).
SMMTSNDXSMMT / SNDX
Capitalization14B1.84B763%
EBITDA-859.78M-178.35M482%
Gain YTD0.658-2.142-31%
P/E Ratio26.36N/A-
Revenue0252M-
Total Cash691M554M125%
Total Debt20.4M589M3%
FUNDAMENTALS RATINGS
SMMT vs SNDX: Fundamental Ratings
SMMT
SNDX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
7580
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4147
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
n/a40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SMMT's Valuation (89) in the Biotechnology industry is in the same range as SNDX (97). This means that SMMT’s stock grew similarly to SNDX’s over the last 12 months.

SMMT's Profit vs Risk Rating (75) in the Biotechnology industry is in the same range as SNDX (80). This means that SMMT’s stock grew similarly to SNDX’s over the last 12 months.

SMMT's SMR Rating (100) in the Biotechnology industry is in the same range as SNDX (100). This means that SMMT’s stock grew similarly to SNDX’s over the last 12 months.

SMMT's Price Growth Rating (41) in the Biotechnology industry is in the same range as SNDX (47). This means that SMMT’s stock grew similarly to SNDX’s over the last 12 months.

SNDX's P/E Growth Rating (4) in the Biotechnology industry is in the same range as SMMT (7). This means that SNDX’s stock grew similarly to SMMT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SMMTSNDX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 4 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
SMMT
Daily Signal:
Gain/Loss:
SNDX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FORH24.730.04
+0.18%
Formidable ETF
XCCC35.330.02
+0.06%
BondBloxx CCC Rated USD HY Corp Bd ETF
QUSA17.91-0.02
-0.11%
Vistashares Target 15 Usa Quality Income ETF
MMIT23.66-0.03
-0.13%
NYLIM MacKay Muni Intermediate ETF
METL28.56-0.25
-0.86%
Sprott Active Metals & Miners ETF

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+2.77%
BCDA - SMMT
70%
Closely correlated
-0.92%
VKTX - SMMT
41%
Loosely correlated
+2.62%
SNDX - SMMT
41%
Loosely correlated
-0.58%
IDYA - SMMT
41%
Loosely correlated
-0.28%
IMNM - SMMT
40%
Loosely correlated
-1.47%
More